Amarantus Bioscience Holdings Inc (AMBS)

[christjamin]

I decided to load up all again@ below0.07 because it is life time bargain. Just look at one of AMBS peer, NVL*. No revenue, just file orphans status for the pancreatic cancer drug, just secured insulin for cell in box tech worldwide for diabetes isvalued @ noth of *165 millions. AMBS valued below 80 million with lympro around the corner, eltoprazine and this orphan filing is more than bargain, it is a steal to me. It is just unbelievable how flippers have succeeded to convince people that the company is worth less than 100 millions. yet NVL* has 710 millions shares, similar to ambs...People are concerned about future dilution with ambs's LPC 20 millions deal. Heuh, NVL* has inked a 50 million deal with another company, more than double what ambs has..By any rational measure, ambs is too much undervalued, too much..